ChiCTR2600128435 clinical trial report covering Rupatifen fumarate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07712913 clinical trial report covering Pregabalin, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07714070 clinical trial report covering Orlistat, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07713745 clinical trial report covering Serplulimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07715565 clinical trial report covering Ipilimumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07715279 clinical trial report covering Vericiguat, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07714668 clinical trial report covering SYS6041, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07715084 clinical trial report covering Nizubaglustat, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07715734 clinical trial report covering Cetuximab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07715097 clinical trial report covering Targeting Survivin DC Cells (Tricision), Phase 2, endpoints, sponsor, geography, readout timing and development whi

NCT07714369 clinical trial report covering Zavegepant, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07715396 clinical trial report covering Tislelizumab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.